These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

461 related articles for article (PubMed ID: 28275074)

  • 1. Same-Day Diagnostic and Surveillance Data for Tuberculosis via Whole-Genome Sequencing of Direct Respiratory Samples.
    Votintseva AA; Bradley P; Pankhurst L; Del Ojo Elias C; Loose M; Nilgiriwala K; Chatterjee A; Smith EG; Sanderson N; Walker TM; Morgan MR; Wyllie DH; Walker AS; Peto TEA; Crook DW; Iqbal Z
    J Clin Microbiol; 2017 May; 55(5):1285-1298. PubMed ID: 28275074
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Real-Time Sequencing of Mycobacterium tuberculosis: Are We There Yet?
    Lee RS; Pai M
    J Clin Microbiol; 2017 May; 55(5):1249-1254. PubMed ID: 28298449
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Application of Targeted Next-Generation Sequencing Assay on a Portable Sequencing Platform for Culture-Free Detection of Drug-Resistant Tuberculosis from Clinical Samples.
    Cabibbe AM; Spitaleri A; Battaglia S; Colman RE; Suresh A; Uplekar S; Rodwell TC; Cirillo DM
    J Clin Microbiol; 2020 Sep; 58(10):. PubMed ID: 32727827
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Direct Whole-Genome Sequencing of Sputum Accurately Identifies Drug-Resistant Mycobacterium tuberculosis Faster than MGIT Culture Sequencing.
    Doyle RM; Burgess C; Williams R; Gorton R; Booth H; Brown J; Bryant JM; Chan J; Creer D; Holdstock J; Kunst H; Lozewicz S; Platt G; Romero EY; Speight G; Tiberi S; Abubakar I; Lipman M; McHugh TD; Breuer J
    J Clin Microbiol; 2018 Aug; 56(8):. PubMed ID: 29848567
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Whole-genome and targeted sequencing of drug-resistant Mycobacterium tuberculosis on the iSeq100 and MiSeq: A performance, ease-of-use, and cost evaluation.
    Colman RE; Mace A; Seifert M; Hetzel J; Mshaiel H; Suresh A; Lemmer D; Engelthaler DM; Catanzaro DG; Young AG; Denkinger CM; Rodwell TC
    PLoS Med; 2019 Apr; 16(4):e1002794. PubMed ID: 31039166
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeted-Sequencing Workflows for Comprehensive Drug Resistance Profiling of Mycobacterium tuberculosis Cultures Using Two Commercial Sequencing Platforms: Comparison of Analytical and Diagnostic Performance, Turnaround Time, and Cost.
    Tafess K; Ng TTL; Lao HY; Leung KSS; Tam KKG; Rajwani R; Tam STY; Ho LPK; Chu CMK; Gonzalez D; Sayada C; Ma OCK; Nega BH; Ameni G; Yam WC; Siu GKH
    Clin Chem; 2020 Jun; 66(6):809-820. PubMed ID: 32402055
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genomic Sequencing from Sputum for Tuberculosis Disease Diagnosis, Lineage Determination, and Drug Susceptibility Prediction.
    Nilgiriwala K; Rabodoarivelo MS; Hall MB; Patel G; Mandal A; Mishra S; Andrianomanana FR; Dingle K; Rodger G; George S; Crook DW; Hoosdally S; Mistry N; Rakotosamimanana N; Iqbal Z; Grandjean Lapierre S; Walker TM
    J Clin Microbiol; 2023 Mar; 61(3):e0157822. PubMed ID: 36815861
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The variability and reproducibility of whole genome sequencing technology for detecting resistance to anti-tuberculous drugs.
    Phelan J; O'Sullivan DM; Machado D; Ramos J; Whale AS; O'Grady J; Dheda K; Campino S; McNerney R; Viveiros M; Huggett JF; Clark TG
    Genome Med; 2016 Dec; 8(1):132. PubMed ID: 28003022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genotypic drug resistance using whole-genome sequencing of Mycobacterium tuberculosis clinical isolates from North-western Tanzania.
    Kidenya BR; Mshana SE; Fitzgerald DW; Ocheretina O
    Tuberculosis (Edinb); 2018 Mar; 109():97-101. PubMed ID: 29559127
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Direct detection of drug-resistant
    Murphy SG; Smith C; Lapierre P; Shea J; Patel K; Halse TA; Dickinson M; Escuyer V; Rowlinson MC; Musser KA
    Front Public Health; 2023; 11():1206056. PubMed ID: 37457262
    [No Abstract]   [Full Text] [Related]  

  • 11. Whole genome enrichment approach for rapid detection of Mycobacterium tuberculosis and drug resistance-associated mutations from direct sputum sequencing.
    Soundararajan L; Kambli P; Priyadarshini S; Let B; Murugan S; Iravatham C; Tornheim JA; Rodrigues C; Gupta R; Ramprasad VL
    Tuberculosis (Edinb); 2020 Mar; 121():101915. PubMed ID: 32279871
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapid, comprehensive, and affordable mycobacterial diagnosis with whole-genome sequencing: a prospective study.
    Pankhurst LJ; Del Ojo Elias C; Votintseva AA; Walker TM; Cole K; Davies J; Fermont JM; Gascoyne-Binzi DM; Kohl TA; Kong C; Lemaitre N; Niemann S; Paul J; Rogers TR; Roycroft E; Smith EG; Supply P; Tang P; Wilcox MH; Wordsworth S; Wyllie D; Xu L; Crook DW;
    Lancet Respir Med; 2016 Jan; 4(1):49-58. PubMed ID: 26669893
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapid detection of Mycobacterium tuberculosis and pyrazinamide susceptibility related to pncA mutations in sputum specimens through an integrated gene-to-protein function approach.
    Li H; Chen J; Zhou M; Geng X; Yu J; Wang W; Zhang XE; Wei H
    J Clin Microbiol; 2014 Jan; 52(1):260-7. PubMed ID: 24226918
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of Whole Genome Sequencing for Mycobacterium tuberculosis Complex Antimicrobial Susceptibility Testing.
    Mohr V; Sonnenkalb L; Utpatel C; Barilar I; Diricks M; Dreyer V; Niemann S; Kohl TA; Merker M
    Methods Mol Biol; 2024; 2833():185-193. PubMed ID: 38949711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of Nanopore sequencing for Mycobacterium tuberculosis drug susceptibility testing and outbreak investigation: a genomic analysis.
    Hall MB; Rabodoarivelo MS; Koch A; Dippenaar A; George S; Grobbelaar M; Warren R; Walker TM; Cox H; Gagneux S; Crook D; Peto T; Rakotosamimanana N; Grandjean Lapierre S; Iqbal Z
    Lancet Microbe; 2023 Feb; 4(2):e84-e92. PubMed ID: 36549315
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Whole-genome sequencing in drug susceptibility testing of Mycobacterium tuberculosis in routine practice in Lyon, France.
    Genestet C; Hodille E; Berland JL; Ginevra C; Bryant JE; Ader F; Lina G; Dumitrescu O;
    Int J Antimicrob Agents; 2020 Apr; 55(4):105912. PubMed ID: 31991222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exploring the potential of Oxford Nanopore Technologies sequencing for Mycobacterium tuberculosis sequencing: An assessment of R10 flowcells and V14 chemistry.
    Dippenaar A; Costa Conceição E; Wells F; Loubser J; Mann B; De Diego Fuertes M; Rennie V; Warren RM; Van Rie A
    PLoS One; 2024; 19(6):e0303938. PubMed ID: 38843147
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rapid Whole-Genome Sequencing of Mycobacterium tuberculosis Isolates Directly from Clinical Samples.
    Brown AC; Bryant JM; Einer-Jensen K; Holdstock J; Houniet DT; Chan JZ; Depledge DP; Nikolayevskyy V; Broda A; Stone MJ; Christiansen MT; Williams R; McAndrew MB; Tutill H; Brown J; Melzer M; Rosmarin C; McHugh TD; Shorten RJ; Drobniewski F; Speight G; Breuer J
    J Clin Microbiol; 2015 Jul; 53(7):2230-7. PubMed ID: 25972414
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapid detection of smear-negative Mycobacterium tuberculosis by PCR and sequencing for rifampin resistance with DNA extracted directly from slides.
    Patnaik M; Liegmann K; Peter JB
    J Clin Microbiol; 2001 Jan; 39(1):51-2. PubMed ID: 11136747
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A quantitative adaptation of the Wayne test for pyrazinamide resistance.
    Meinzen C; Proaño A; Gilman RH; Caviedes L; Coronel J; Zimic M; Sheen P
    Tuberculosis (Edinb); 2016 Jul; 99():41-46. PubMed ID: 27450003
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.